Survivors of hematopoietic stem cell transplantation (HSCT) generally have multiple long term health problems related to:
- Therapy:
- Chemotherapy and/or radiation therapy
- Chronic graft versus host disease (cGvHD)
- Other factors may also play a role:
- Previous malignancy
- Complications during transplant (such as septicaemia and hypotension)
- Supportive therapy (such as nephrotoxic antibiotics and antifungal therapy)
Usually these side effects overlap and produce significant morbidity.
Armenian et al compared the risk of chronic health problems in cancer survivors treated only with conventional chemotherapy, those treated with HSCT and in the siblings of cancer survivors. Severe, chronic health conditions were far more common in survivors treated with HSCT. Undergoing HSCT from an unrelated donor or a conditioning regime that included TBI (whole body RT) was associated with an increased risk of severe adverse health conditions. Survivors after HSCT were more likely to have endocrine problems (especially gonadal failure in women), neurosensory impairments, second malignant neoplasms (6.9%) and cardiovascular disease (4.8%).
Late Effects of therapy:
Radiation therapy (RT):
Whole body low dose RT (often called Total Body Irradiation or TBI) can affect many organs and lead to multiple late effects. These side effects are exacerbated by the high dose chemotherapy also given as part of the conditioning regime.
Examples of long term health problems related to RT component of conditioning regime:
Region affected by TBI | Long-term health Risk |
General |
|
|
|
Skeletal |
|
Brain |
|
|
|
Eyes |
|
Pituitary Hypothalamus |
|
Oral |
|
|
|
Thyroid |
|
|
|
Lungs |
|
Heart |
|
Kidneys |
|
|
|
Gonads |
|
Immune system |
|
Chemotherapy:
Examples of late health problems related to the chemotherapy component of conditioning regime:
- Cyclophosphamide is directly responsible for:
- Infertility
- Increased risk of secondary leukemia
- Bleomycin is directly responsible for:
- Pulmonary damage
Chronic graft versus host disease (cGvHD):
cGvHD affects many organs, but the major targets are: